Recombinant AAV9-TLK1B Administration Ameliorates Fractionated Radiation-Induced Xerostomia

Male Recombination, Genetic 0301 basic medicine 0303 health sciences Genetic Vectors Submandibular Gland Acinar Cells Dependovirus Protein Serine-Threonine Kinases Xerostomia Cell Line Rats 3. Good health Rats, Sprague-Dawley 03 medical and health sciences HEK293 Cells Transduction, Genetic Animals Humans Dose Fractionation, Radiation Transgenes Radiation Injuries Salivation
DOI: 10.1089/hum.2012.235 Publication Date: 2013-04-24T15:53:40Z
ABSTRACT
Salivary glands are highly susceptible to radiation, and patients with head neck cancer treated radiotherapy invariably suffer from its distressing side effect, salivary hypofunction. The reduction in saliva disrupts oral functions, significantly impairs health. Previously, we demonstrated that adenoviral-mediated expression of Tousled-like kinase 1B (TLK1B) rat submandibular preserves function after single-dose ionizing radiation. To achieve long-term transgene for protection gland against fractionated this study examines the usefulness recombinant adeno-associated viral vector TLK1B delivery. Lactated Ringers or AAV2/9 either GFP cassette were retroductally delivered (10(11) vg/gland), animals exposed, not, 20 Gy eight fractions 2.5 Gy/day. transduced predominantly ductal cells, including convoluted granular tubules glands. Transgene virus delivery could be detected within 5 weeks, stable gene was observed till end study. Pilocarpine-stimulated output measured at 8 weeks completion radiation >10-fold flow saline- AAV2/9-GFP-treated compared respective nonirradiated groups (90.8% 92.5% flow, respectively). Importantly, there no decrease stimulated irradiation pretreated AAV2/9-TLK1B (121.5% increase flow; p<0.01). histology better preserved TLK1B-treated group, though not significantly, control groups. Single preemptive averts dysfunction resulting Although transduces mostly cells gland, their assists preserving function. treatment prove beneficial attenuating xerostomia undergoing radiotherapy.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (22)